Wild, Wild West of Cannabidiol (CBD): Is it Possible to Hold CBD to the Same Standards as Other Medicines to Protect Consumers, Patients, and Clinicians
9:00 AM - 10:15 AM, Thursday, June 11, 2020 ・ Room 2
Currently, companies are creating a myriad of CBD products largely unburdened by any oversight or testing requirements. The inherent complexity of CBD, combined with the danger of hazardous additives, raises serious public health concerns that absent some rules or regulations, unscrupulous companies will be able to distribute products that include illegal CBD combinations or have dangerous additives. Despite a dearth of reliable scientific evidence, the belief in efficacy, fueled by pseudoscience, testimonials, media reporting of same, has resulted in a torrent of interest in cannabis not just as a wellness product but as a medicine for serious conditions. Consumers, including patients, clinicians, and researchers, are acutely interested in understanding if and how CBD can be used safely and effectively to address unmet health issues.